Sale of our stake in CoorpAcademy to Go1

With this investment from 2014, Après-demain SA has supported the different development phases of CoorpAcademy allowing them to become a leading European company in the area of Corporate Digital Learning, offering more than 1800 courses and counting among its customers more than 120 large companies. Beyond the investment, Debiopharm has developed materials with CoorpAcademy for the training of our commercial partners on Triptoreline (prostate cancer, breast cancer, precocious puberty).

Based in Paris and in Lausanne on the campus of the Swiss Federal Institute of Technology (EPFL), CoorpAcademy has benefited from close collaborations with the Digital Learning Center which has enabled them to propose innovations in educational design, including gamification, microlearning, adaptive and social learning.

Link to their press release